• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
  

PubMed=1500230; DOI=10.1002/ijc.2910520115
Volker J. Mobus, Claus-Dieter Gerharz, U. Press, Roland Moll, Timothy Beck, Walter Mellin, Kunhard Pollow, Paul-Georg Knapstein, Rolf Kreienberg;
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines.
Int. J. Cancer 52:76-84(1992)

PubMed=21559638; DOI=10.3892/ijo.5.4.753
Christine Will, Olaf G. Wilhelm, Sandra Hohl, Volker J. Mobus, Ulrich H. Weidle, Rolf Kreienberg, Fritz Janicke, Manfred Schmitt, Henner Graeff;
Expression of urokinase-type plasminogen-activator (uPA) and its receptor (uPAR) in human ovarian-cancer cells and in-vitro invasion capacity.
Int. J. Oncol. 5:753-761(1994)

PubMed=11242531; DOI=10.1089/10430340150504019
Ansgar Bruning, Tanja Kohler, Sven Roy Quist, Shan Wang-Gohrke, Volker J. Mobus, Rolf Kreienberg, Ingo Bernard Runnebaum;
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3.
Hum. Gene Ther. 12:391-399(2001)

PubMed=15153938; DOI=10.1038/sj.cgt.7700727
Sven Roy Quist, Shan Wang-Gohrke, Tanja Kohler, Rolf Kreienberg, Ingo Bernard Runnebaum;
Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
Cancer Gene Ther. 11:547-554(2004)

DOI=10.5282/edoc.3898
Nicole Isabel Euer;
Identification of target genes for the therapy and diagnosis of ovarian carcinoma.
Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany

PubMed=15706405; DOI=10.3892/or.13.3.375
Nicole Isabel Euer, Sepp Kaul, Helmut Deissler, Volker J. Mobus, Robert Zeillinger, Ulrich H. Weidle;
Identification of L1CAM, Jagged2 and neuromedin U as ovarian cancer-associated antigens.
Oncol. Rep. 13:375-387(2005)